EGFR and breast carcinoma: Coactivator overexpression in human breast cancer cell lines increased proliferation with resistance to PPAR and RXR ligands and remodeled chromatin of the proximal epidermal growth factor receptor promoter, which is a principal growth signaling pathway in mammary epithelial cells.